drugset / Trial / NCT04298034

Preeclampsia Postpartum Antihypertensive Treatment

NCT04298034

Phase 3 Active not recruiting 300 enrolled Medical College of Wisconsin
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this study is to compare whether antihypertensive treatment in the postpartum period decreases postpartum hypertension and its associated maternal morbidity, including risk of readmission and healthcare utilization in comparison with no treatment. Women with preeclampsia diagnosed during the antepartum, intrapartum or postpartum period will be randomized to either initiate antihypertensive treatment or standard of care. We hypothesize that postpartum antihypertensive treatment of patients with preeclampsia will decrease risk of hospital readmission, healthcare utilization and the number of severe range blood pressures at postpartum follow-up visits.

Timeline

Start
2020-07-17
Primary completion
2025-06-30
Completion
2026-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Labetalol Small molecule
Subject Nifedipine Other / unclassified

Indications